GALAPAGOS N.V.GALAPAGOS N.V.GALAPAGOS N.V.

GALAPAGOS N.V.

No trades
See on Supercharts
Market capitalization
‪1.82 B‬EUR
−2.325EUR
‪211.70 M‬EUR
‪239.72 M‬EUR
‪44.55 M‬
Beta (1Y)
0.53

About GALAPAGOS N.V.

CEO
Paulus Stoffels
Website
Headquarters
Mechelen
Employees (FY)
‪1.12 K‬
Founded
1999
ISIN
BE0003818359
FIGI
BBG000GD4QH3
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange GALAPAGOS N.V. stocks are traded under the ticker GXE.
GALAPAGOS N.V. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
GXE earnings for the last quarter are 0.39 EUR per share, whereas the estimation was −1.03 EUR resulting in a 137.76% surprise. The estimated earnings for the next quarter are −1.97 EUR per share. See more details about GALAPAGOS N.V. earnings.
GALAPAGOS N.V. revenue for the last quarter amounts to ‪120.05 M‬ EUR despite the estimated figure of ‪83.78 M‬ EUR. In the next quarter revenue is expected to reach ‪73.22 M‬ EUR.
Yes, you can track GALAPAGOS N.V. financials in yearly and quarterly reports right on TradingView.
GXE net income for the last quarter is ‪25.83 M‬ EUR, while the quarter before that showed ‪5.10 M‬ EUR of net income which accounts for 406.37% change. Track more GALAPAGOS N.V. financial stats to get the full picture.
No, GXE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GXE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GALAPAGOS N.V. stock right from TradingView charts — choose your broker and connect to your account.
GXE reached its all-time high on Feb 19, 2020 with the price of 248.400 EUR, and its all-time low was 4.675 EUR and was reached on Aug 8, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪1.12 K‬ employees. See our rating of the largest employees — is GALAPAGOS N.V. on this list?
We've gathered analysts' opinions on GALAPAGOS N.V. future price: according to them, GXE price has a max estimate of 62.00 EUR and a min estimate of 30.00 EUR. Read a more detailed GALAPAGOS N.V. forecast: see what analysts think of GALAPAGOS N.V. and suggest that you do with its stocks.